GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment

Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Today
—
Total
BSE
Exchange
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Sanofi India Ltd
Sanofi India Appoints Debajit Roy as Senior Management
MANAGEMENT ● No Immediate Change LOW RISK
📅 Filed on BSE: 03 Jun 2026, 12:11 PM IST  ·  BSE ID: c31bc793-4e2c-4464-9cf8-ceca3e16db81
View Original BSE Filing (PDF)
💡
In Simple Terms
Sanofi India has named a new senior manager to lead its diabetes sales and customer engagement efforts.
🤖 AI Summary
  • Mr. Debajit Roy appointed Sales & Customer Engagement Head – Diabetes.
  • Role designated as Senior Management Personnel within Sanofi India Ltd.
  • Appointment effective from June 8, 2026.
  • Board approved the appointment via circular resolution on June 3, 2026.
🏢 How This Affects the Company
📈
Business Impact
This appointment strengthens the company's leadership in the critical diabetes segment, potentially impacting sales strategies and market engagement.
⚙️
Operational Impact
The appointment signals a focus on specialized leadership within the sales force, impacting the structure and direction of the diabetes business unit.
👥 What This Means For Shareholders
✅
Action Required
No action is required from shareholders. This is an internal management change.
👤
Who Is Affected
This appointment affects internal stakeholders responsible for the diabetes business unit's performance and strategic direction.
🔍
Management Signal
The appointment signals a commitment to dedicated leadership for the crucial diabetes segment, indicating strategic focus.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Subsequent quarterly results to assess diabetes segment performance.
Company announcements regarding leadership team integration.
Further management appointments or changes in key roles.
LOW RISK The filing details a routine senior management appointment.
💡 Investor Takeaway
Sanofi India has appointed Mr. Debajit Roy as Senior Management Personnel for Sales & Customer Engagement in Diabetes, effective June 8, 2026.
❓ Frequently Asked Questions
Who has Sanofi India appointed as Senior Management Personnel?
Sanofi India has appointed Mr. Debajit Roy as Sales & Customer Engagement Head – Diabetes.
When is the appointment of Mr. Debajit Roy effective?
The appointment of Mr. Debajit Roy is effective from June 8, 2026.
What is Mr. Debajit Roy's designation at Sanofi India?
Mr. Debajit Roy's designation is Sales & Customer Engagement Head – Diabetes, and he is designated as Senior Management Personnel.
Which department will Mr. Debajit Roy lead at Sanofi India?
Mr. Debajit Roy will lead the Sales & Customer Engagement for the Diabetes segment at Sanofi India.

Questions based on this BSE filing only. For information purposes.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.